Tie receptor tyrosine kinase ligand homologues
CA 2304810 C · Owner: Fong, Sherman · Inventors: Fong, Sherman; Gurney, Austin L.; Godowski, Paul J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligand homologues NL2, NL3 and NL6 (FLS139) the proteins encoded by , such nucleic acid molecules as well as methods and means for making and using such nucleic acid and protein molecules.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 14, 1998 and granted May 10, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 14, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 14, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.